期刊
BIOMARKERS
卷 17, 期 8, 页码 671-691出版社
INFORMA HEALTHCARE
DOI: 10.3109/1354750X.2012.715672
关键词
Antioxidant; cancer; biomarker; patients; response; oxidative stress
资金
- NIH/NCI [CA114365]
This review summarizes clinical studies in which glutathione was measured in tumor tissue from patients with brain, breast, gastrointestinal, gynecological, head and neck and lung cancer. Glutathione tends to be elevated in breast, ovarian, head and neck, and lung cancer and lower in brain and liver tumors compared to disease-free tissue. Cervical, colorectal, gastric, and esophageal cancers show both higher and lower levels of tumor glutathione. Some studies show an inverse relationship between patient survival and tumor glutathione. Based on this survey, we recommend approaches that may improve the clinical value of glutathione as a biomarker.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据